Fig. 2From: Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational studyPreliminary study. a Plasma sTGFβrIII expression levels at different parts of the ovarian cycle in 13 healthy women aged 19-40 years. b Plasma sTGFβrIII expression levels at different times of the day in 15 hospitalized women with breast cancer AJCC stage 0-IIB (prior to surgery), aged 35-75 yearsBack to article page